These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37691856)

  • 1. Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy.
    Garland KM; Kwiatkowski AJ; Tossberg JT; Crooke PS; Aune TM; Wilson JT
    Cancer Res Commun; 2023 Sep; 3(9):1800-1809. PubMed ID: 37691856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.
    Tossberg JT; Heinrich RM; Farley VM; Crooke PS; Aune TM
    J Immunol; 2020 Nov; 205(10):2606-2617. PubMed ID: 33046502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.
    Aune TM; Tossberg JT; Heinrich RM; Porter KP; Crooke PS
    Front Immunol; 2022; 13():818023. PubMed ID: 35126398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer's disease.
    Crooke PS; Tossberg JT; Heinrich RM; Porter KP; Aune TM
    Brain Commun; 2022; 4(5):fcac238. PubMed ID: 36196083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    Crooke PS; Tossberg JT; Porter KP; Aune TM
    J Immunol; 2021 Apr; 206(8):1691-1696. PubMed ID: 33782089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of
    Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K
    RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.
    Heinrich MJ; Purcell CA; Pruijssers AJ; Zhao Y; Spurlock CF; Sriram S; Ogden KM; Dermody TS; Scholz MB; Crooke PS; Karijolich J; Aune TM
    J Autoimmun; 2019 Jun; 100():40-51. PubMed ID: 30826177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
    Heraud-Farlow JE; Walkley CR
    Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation.
    Kawahara Y; Nishikura K
    FEBS Lett; 2006 Apr; 580(9):2301-5. PubMed ID: 16574103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy.
    Heidegger S; Stritzke F; Dahl S; Daßler-Plenker J; Joachim L; Buschmann D; Fan K; Sauer CM; Ludwig N; Winter C; Enssle S; Li S; Perl M; Görgens A; Haas T; Orberg ET; Göttert S; Wölfel C; Engleitner T; Cortés-Ciriano I; Rad R; Herr W; Giebel B; Ruland J; Bassermann F; Coch C; Hartmann G; Poeck H
    Cell Rep Med; 2023 Sep; 4(9):101171. PubMed ID: 37657445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
    Nakahama T; Kawahara Y
    Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
    Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
    Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy.
    Yuan J; Xu L; Bao HJ; Wang JL; Zhao Y; Chen S
    J Exp Clin Cancer Res; 2023 Jun; 42(1):149. PubMed ID: 37328893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
    Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.
    Wang-Bishop L; Wehbe M; Pastora LE; Yang J; Kimmel BR; Garland KM; Becker KW; Carson CS; Roth EW; Gibson-Corley KN; Ulkoski D; Krishnamurthy V; Fedorova O; Richmond A; Pyle AM; Wilson JT
    ACS Nano; 2024 May; 18(18):11631-11643. PubMed ID: 38652829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of widespread ultra-edited human RNAs.
    Carmi S; Borukhov I; Levanon EY
    PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of hepatocellular carcinoma with small double-stranded RNA.
    Kabilova TO; Kovtonyuk LV; Zonov EV; Ryabchikova EI; Popova NA; Nikolin VP; Kaledin VI; Zenkova MA; Vlassov VV; Chernolovskaya EL
    BMC Cancer; 2014 May; 14():338. PubMed ID: 24886485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
    Crooke PS; Tossberg JT; Porter KP; Aune TM
    Curr Res Immunol; 2021; 2():52-59. PubMed ID: 33969287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.
    Aktaş T; Avşar Ilık İ; Maticzka D; Bhardwaj V; Pessoa Rodrigues C; Mittler G; Manke T; Backofen R; Akhtar A
    Nature; 2017 Apr; 544(7648):115-119. PubMed ID: 28355180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.